RELPAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Relpax, and what generic alternatives are available?
Relpax is a drug marketed by Upjohn and is included in one NDA.
The generic ingredient in RELPAX is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Relpax
A generic version of RELPAX was approved as eletriptan hydrobromide by ZYDUS PHARMS on June 16th, 2017.
Summary for RELPAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Clinical Trials: | 3 |
Patent Applications: | 2,672 |
Drug Prices: | Drug price information for RELPAX |
What excipients (inactive ingredients) are in RELPAX? | RELPAX excipients list |
DailyMed Link: | RELPAX at DailyMed |
Recent Clinical Trials for RELPAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 1 |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 |
GlaxoSmithKline | Phase 3 |
Pharmacology for RELPAX
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for RELPAX
Paragraph IV (Patent) Challenges for RELPAX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
RELPAX | Tablets | eletriptan hydrobromide | 20 mg and 40 mg | 021016 | 1 | 2010-03-29 |
US Patents and Regulatory Information for RELPAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RELPAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-001 | Dec 26, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Upjohn | RELPAX | eletriptan hydrobromide | TABLET;ORAL | 021016-002 | Dec 26, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RELPAX
See the table below for patents covering RELPAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 9106978 | ⤷ Try a Trial | |
Yugoslavia | 49287 | ⤷ Try a Trial | |
Iceland | 1850 | ⤷ Try a Trial | |
China | 1155886 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RELPAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0592438 | C00592438/01 | Switzerland | ⤷ Try a Trial | FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH |
0592438 | 36/2001 | Austria | ⤷ Try a Trial | PRODUCT NAME: ELETRIPTAN UND DIE PHARMAZEUTISCH VERTRAEGLICHEN SALZE DAVON, EINSCHLIESSLICH DES HYDROBROMIDS; NAT. REGISTRATION NO/DATE: 1-24155 20010801; FIRST REGISTRATION: LI 55218 01, 55218 02 20001214 |
0592438 | SPC/GB01/023 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ELETRIPTAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE HYDROBROMIDE SALT; REGISTERED: CH 55218 01 20001214; CH 52218 02 20001214; CH 52218 03 20001214; UK PL 00057/0452 20010212; UK PL 00057/0453 20010212; UK PL 00057/0454 20010212 |
0592438 | 02C0013 | France | ⤷ Try a Trial | PRODUCT NAME: ELETRIPTAN HYDROBROMIDE; NAT. REGISTRATION NO/DATE: NL 26625 20011105; FIRST REGISTRATION: LI - IKS 55218 20001214 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |